- Home
- CDXS vs CAF Comparison
CDXS vs CAF Comparison
Compare CDXS & CAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- CAF
- Stock Information
- Founded
- CDXS 2002
- CAF 2006
- Country
- CDXS United States
- CAF United States
- Employees
- CDXS N/A
- CAF N/A
- Industry
- CDXS Major Chemicals
- CAF Investment Managers
- Sector
- CDXS Industrials
- CAF Finance
- Exchange
- CDXS Nasdaq
- CAF Nasdaq
- Market Cap
- CDXS 201.3M
- CAF 227.6M
- IPO Year
- CDXS 2010
- CAF N/A
- Fundamental
- Price
- CDXS $3.04
- CAF $14.10
- Analyst Decision
- CDXS Buy
- CAF
- Analyst Count
- CDXS 2
- CAF 0
- Target Price
- CDXS $11.00
- CAF N/A
- AVG Volume (30 Days)
- CDXS 910.6K
- CAF 63.6K
- Earning Date
- CDXS 08-07-2025
- CAF 01-01-0001
- Dividend Yield
- CDXS N/A
- CAF 1.02%
- EPS Growth
- CDXS N/A
- CAF N/A
- EPS
- CDXS N/A
- CAF N/A
- Revenue
- CDXS $49,815,000.00
- CAF N/A
- Revenue This Year
- CDXS $12.77
- CAF N/A
- Revenue Next Year
- CDXS $22.12
- CAF N/A
- P/E Ratio
- CDXS N/A
- CAF N/A
- Revenue Growth
- CDXS N/A
- CAF N/A
- 52 Week Low
- CDXS $1.90
- CAF $11.63
- 52 Week High
- CDXS $6.08
- CAF $14.38
- Technical
- Relative Strength Index (RSI)
- CDXS 69.54
- CAF 70.60
- Support Level
- CDXS $2.55
- CAF $13.61
- Resistance Level
- CDXS $2.91
- CAF $13.85
- Average True Range (ATR)
- CDXS 0.20
- CAF 0.13
- MACD
- CDXS 0.06
- CAF 0.01
- Stochastic Oscillator
- CDXS 96.17
- CAF 91.76
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About CAF Morgan Stanley China A Share Fund Inc.
Morgan Stanley China A Share Fund Inc is the United States based non-diversified, closed-end management investment company. Its investment objective is to seek capital growth by investing a majority of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges. Its portfolio of investments consists of investment in different sectors such as the aerospace and defense, banks, automobiles, household durables, media, pharmaceuticals, software and other sectors.